207 related articles for article (PubMed ID: 28132696)
1. Socioeconomic and geographic disparities in access to pharmacotherapy for alcohol dependence.
Morley KC; Logge W; Pearson SA; Baillie A; Haber PS
J Subst Abuse Treat; 2017 Mar; 74():23-25. PubMed ID: 28132696
[TBL] [Abstract][Full Text] [Related]
2. New pharmacotherapies for alcohol dependence.
Graham R; Wodak AD; Whelan G
Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
[TBL] [Abstract][Full Text] [Related]
3. National trends in alcohol pharmacotherapy: Findings from an Australian claims database.
Morley KC; Logge W; Pearson SA; Baillie A; Haber PS
Drug Alcohol Depend; 2016 Sep; 166():254-7. PubMed ID: 27394934
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in India.
Basu D; Jhirwal OP; Mattoo SK
Am J Addict; 2005; 14(4):381-95. PubMed ID: 16188718
[TBL] [Abstract][Full Text] [Related]
5. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
Buri C; Moggi F; Giovanoli A; Strik W
Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
[TBL] [Abstract][Full Text] [Related]
6. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
Snyder JL; Bowers TG
Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.
Harris AHS; Ellerbe L; Reeder RN; Bowe T; Gordon AJ; Hagedorn H; Oliva E; Lembke A; Kivlahan D; Trafton JA
Psychol Serv; 2013 Nov; 10(4):410-419. PubMed ID: 23356858
[TBL] [Abstract][Full Text] [Related]
9. [The pharmacologic treatment of the alcohol dependence].
Castro LA; Baltieri DA
Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
[TBL] [Abstract][Full Text] [Related]
10. [Acamprosate and naltrexone: similar efficacy for relapse].
Saitz R
Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019
[No Abstract] [Full Text] [Related]
11. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
Kranzler HR; Van Kirk J
Alcohol Clin Exp Res; 2001 Sep; 25(9):1335-41. PubMed ID: 11584154
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Bouza C; Angeles M; Muñoz A; Amate JM
Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
[TBL] [Abstract][Full Text] [Related]
14. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
Baser O; Chalk M; Rawson R; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for Adults with Alcohol Use Disorder.
Salisbury-Afshar E
Am Fam Physician; 2016 Jul; 94(2):155-7. PubMed ID: 27419333
[No Abstract] [Full Text] [Related]
17. Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption.
Robinson S; Bowe T; Harris AH
J Subst Abuse Treat; 2013; 45(5):475-7. PubMed ID: 23932227
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological treatment of alcohol dependence. Acamprosate and naltrexone offer new approach].
Berglund M; Balldin J; Bendtsen P; Borg S; Franck J; Gustafsson L; Halldin J; Månsson M; Nilsson LH; Stolt G; Willander A
Lakartidningen; 1997 Jul; 94(30-31):2645-8. PubMed ID: 9273426
[No Abstract] [Full Text] [Related]
19. Recent advances in the pharmacotherapy of alcoholism.
Myrick H; Anton R
Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
[TBL] [Abstract][Full Text] [Related]
20. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
